Equity Ab Frankenius - Net Worth and Insider Trading
Equity Ab Frankenius Net Worth
The estimated net worth of Equity Ab Frankenius is at least $31 Million dollars as of 2024-12-27. Equity Ab Frankenius is the 10% Owner of TriSalus Life Sciences Inc and owns about 6,230,748 shares of TriSalus Life Sciences Inc (TLSI) stock worth over $31 Million. Details can be seen in Equity Ab Frankenius's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Equity Ab Frankenius has not made any transactions after 2024-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Equity Ab Frankenius
Equity Ab Frankenius Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Equity Ab Frankenius owns 2 companies in total, including TriSalus Life Sciences Inc (TLSI) , and MedTech Acquisition Corp (MTAC) .
Click here to see the complete history of Equity Ab Frankenius’s form 4 insider trades.
Insider Ownership Summary of Equity Ab Frankenius
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TLSI | TriSalus Life Sciences Inc | 2024-12-17 | 10 percent owner |
MTAC | MedTech Acquisition Corp | 2023-08-10 | 10 percent owner |
Equity Ab Frankenius Latest Holdings Summary
Equity Ab Frankenius currently owns a total of 1 stock. Equity Ab Frankenius owns 6,230,748 shares of TriSalus Life Sciences Inc (TLSI) as of December 17, 2024, with a value of $31 Million.
Latest Holdings of Equity Ab Frankenius
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TLSI | TriSalus Life Sciences Inc | 2024-12-17 | 6,230,748 | 4.99 | 31,091,433 |
Holding Weightings of Equity Ab Frankenius
Equity Ab Frankenius Form 4 Trading Tracker
According to the SEC Form 4 filings, Equity Ab Frankenius has made a total of 1 transactions in TriSalus Life Sciences Inc (TLSI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TriSalus Life Sciences Inc is the acquisition of 62,972 shares on December 17, 2024, which cost Equity Ab Frankenius around $249,999.
Insider Trading History of Equity Ab Frankenius
- 1
Equity Ab Frankenius Trading Performance
Equity Ab Frankenius Ownership Network
Equity Ab Frankenius Owned Company Details
What does TriSalus Life Sciences Inc do?
Who are the key executives at TriSalus Life Sciences Inc?
Equity Ab Frankenius is the 10 percent owner of TriSalus Life Sciences Inc. Other key executives at TriSalus Life Sciences Inc include director & 10 percent owner Mats Wahlstrom , Chief Scientific & Manufact. Bryan F. Cox , and director & CEO and President Mary T Szela .
TriSalus Life Sciences Inc (TLSI) Insider Trades Summary
Over the past 18 months, Equity Ab Frankenius made 1 insider transaction in TriSalus Life Sciences Inc (TLSI) with a net purchase of 62,972. Other recent insider transactions involving TriSalus Life Sciences Inc (TLSI) include a net purchase of 19,815 shares made by Mary T Szela , a net purchase of 15,727 shares made by Mats Wahlstrom , and a net sale of 30,000 shares made by Arjun Jj Desai .
In summary, during the past 3 months, insiders sold 30,314 shares of TriSalus Life Sciences Inc (TLSI) in total and bought 78,699 shares, with a net purchase of 48,385 shares. During the past 18 months, 30,323 shares of TriSalus Life Sciences Inc (TLSI) were sold and 98,514 shares were bought by its insiders, resulting in a net purchase of 68,191 shares.
TriSalus Life Sciences Inc (TLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.
TriSalus Life Sciences Inc Insider Transactions
Equity Ab Frankenius Mailing Address
Above is the net worth, insider trading, and ownership report for Equity Ab Frankenius. You might contact Equity Ab Frankenius via mailing address: Box 984, Boras V7 Se-501 10.